Atlas Trials

Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer

Clinical trial NCT01324583 · COMPLETED

Trial details

NCT number
NCT01324583
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2011-01-01
Primary completion
2014-11-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.